Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients

Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...

Full description

Saved in:
Bibliographic Details
Published inJournal of Clinical Microbiology Vol. 33; no. 4; pp. 878 - 884
Main Authors Pinon, J M, Foudrinier, F, Mougeot, G, Marx, C, Aubert, D, Toupance, O, Niel, G, Danis, M, Camerlynck, P, Remy, G
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.04.1995
Subjects
Online AccessGet full text
ISSN0095-1137
1098-660X
1070-633X
1098-660X
DOI10.1128/jcm.33.4.878-884.1995

Cover

Abstract Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JCM .asm.org, visit: JCM       
AbstractList To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by means of immunocapture (IC) tests, with revelation done by using a suspension of T. gondii (ICT). We also carried out a simultaneous analytical study of IgG antibodies on cellulose acetate membranes by using the comparative immunological profile method and an enzyme-linked immunofiltration assay (ELIFA). A total of 1,238 samples (serum, cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA and IgE antibodies were detected in all heart, kidney, and liver transplant recipients with clinical manifestations of toxoplasmosis; IgA was detected in the aqueous humor of a patient with chorioretinitis. In patients with AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE antibodies or a significant modification of ELIFA IgG values were observed in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests for specific IgA and IgE alone and combined with ELIFA were positive in 39 and 46% of patients who developed clinical toxoplasmosis, respectively. In a serial study of 16 patients in whom at least one of these three tests was positive, a significant immunological signal sometimes preceded clinical onset by 1, 6, and even 17 months. Similarly, in a group of human immunodeficiency virus-infected patients with evidence of previous exposure to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE antibodies were detected in only 11, 4, and 12% of patients, respectively. These two situations point to peripheral T. gondii reactivation. IgA and IgE emerged as interesting markers of the risk of toxoplasmosis in immunodepressed patients. They may also provide valuable assistance in the diagnosis of toxoplasmosis, especially because tests for specific IgM are disappointing. However, at least one in two patients with toxoplasmosis showed no detectable immunological reaction, suggesting that this polyisotypic approach should be combined with other noninvasive methods such as gene amplification.To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by means of immunocapture (IC) tests, with revelation done by using a suspension of T. gondii (ICT). We also carried out a simultaneous analytical study of IgG antibodies on cellulose acetate membranes by using the comparative immunological profile method and an enzyme-linked immunofiltration assay (ELIFA). A total of 1,238 samples (serum, cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA and IgE antibodies were detected in all heart, kidney, and liver transplant recipients with clinical manifestations of toxoplasmosis; IgA was detected in the aqueous humor of a patient with chorioretinitis. In patients with AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE antibodies or a significant modification of ELIFA IgG values were observed in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests for specific IgA and IgE alone and combined with ELIFA were positive in 39 and 46% of patients who developed clinical toxoplasmosis, respectively. In a serial study of 16 patients in whom at least one of these three tests was positive, a significant immunological signal sometimes preceded clinical onset by 1, 6, and even 17 months. Similarly, in a group of human immunodeficiency virus-infected patients with evidence of previous exposure to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE antibodies were detected in only 11, 4, and 12% of patients, respectively. These two situations point to peripheral T. gondii reactivation. IgA and IgE emerged as interesting markers of the risk of toxoplasmosis in immunodepressed patients. They may also provide valuable assistance in the diagnosis of toxoplasmosis, especially because tests for specific IgM are disappointing. However, at least one in two patients with toxoplasmosis showed no detectable immunological reaction, suggesting that this polyisotypic approach should be combined with other noninvasive methods such as gene amplification.
To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by means of immunocapture (IC) tests, with revelation done by using a suspension of T. gondii (ICT). We also carried out a simultaneous analytical study of IgG antibodies on cellulose acetate membranes by using the comparative immunological profile method and an enzyme-linked immunofiltration assay (ELIFA). A total of 1,238 samples (serum, cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA and IgE antibodies were detected in all heart, kidney, and liver transplant recipients with clinical manifestations of toxoplasmosis; IgA was detected in the aqueous humor of a patient with chorioretinitis. In patients with AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE antibodies or a significant modification of ELIFA IgG values were observed in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests for specific IgA and IgE alone and combined with ELIFA were positive in 39 and 46% of patients who developed clinical toxoplasmosis, respectively. In a serial study of 16 patients in whom at least one of these three tests was positive, a significant immunological signal sometimes preceded clinical onset by 1, 6, and even 17 months. Similarly, in a group of human immunodeficiency virus-infected patients with evidence of previous exposure to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE antibodies were detected in only 11, 4, and 12% of patients, respectively. These two situations point to peripheral T. gondii reactivation. IgA and IgE emerged as interesting markers of the risk of toxoplasmosis in immunodepressed patients. They may also provide valuable assistance in the diagnosis of toxoplasmosis, especially because tests for specific IgM are disappointing. However, at least one in two patients with toxoplasmosis showed no detectable immunological reaction, suggesting that this polyisotypic approach should be combined with other noninvasive methods such as gene amplification.
To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by means of immunocapture (IC) tests, with revelation done by using a suspension of T. gondii (ICT). We also carried out a simultaneous analytical study of IgG antibodies on cellulose acetate membranes by using the comparative immunological profile method and an enzyme-linked immunofiltration assay (ELIFA). A total of 1,238 samples (serum, cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA and IgE antibodies were detected in all heart, kidney, and liver transplant recipients with clinical manifestations of toxoplasmosis; IgA was detected in the aqueous humor of a patient with chorioretinitis. In patients with AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE antibodies or a significant modification of ELIFA IgG values were observed in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests for specific IgA and IgE alone and combined with ELIFA were positive in 39 and 46% of patients who developed clinical toxoplasmosis, respectively. In a serial study of 16 patients in whom at least one of these three tests was positive, a significant immunological signal sometimes preceded clinical onset by 1, 6, and even 17 months. Similarly, in a group of human immunodeficiency virus-infected patients with evidence of previous exposure to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE antibodies were detected in only 11, 4, and 12% of patients, respectively.
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JCM .asm.org, visit: JCM       
Author P Camerlynck
D Aubert
G Mougeot
F Foudrinier
G Remy
J M Pinon
C Marx
G Niel
O Toupance
M Danis
AuthorAffiliation Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
AuthorAffiliation_xml – name: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
Author_xml – sequence: 1
  givenname: J M
  surname: Pinon
  fullname: Pinon, J M
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 2
  givenname: F
  surname: Foudrinier
  fullname: Foudrinier, F
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 3
  givenname: G
  surname: Mougeot
  fullname: Mougeot, G
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 4
  givenname: C
  surname: Marx
  fullname: Marx, C
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 5
  givenname: D
  surname: Aubert
  fullname: Aubert, D
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 6
  givenname: O
  surname: Toupance
  fullname: Toupance, O
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 7
  givenname: G
  surname: Niel
  fullname: Niel, G
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 8
  givenname: M
  surname: Danis
  fullname: Danis, M
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 9
  givenname: P
  surname: Camerlynck
  fullname: Camerlynck, P
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
– sequence: 10
  givenname: G
  surname: Remy
  fullname: Remy, G
  organization: Laboratoire de Parasitologie, Eq 5 Institut National de la Santé et de la Recherche Médicale (Unité 314), Reims, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3466266$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7790453$$D View this record in MEDLINE/PubMed
BookMark eNqNksFu1DAQhiNUVLaFR6jkA0JUahY7jmNHiMOqWspKRVyKxM2aJE7WxbHTONmyT9dXw9ldFcqlnEaa-b-Zsf85iY6ssyqKzgieE5KID7dlO6d0ns4FF7EQ6ZzkOXsRzQjORZxl-MdRNMM4ZzEhlL-KTry_xZikKWPH0THnOU4ZnUUPyw2YEQbtLHI16rX_icBWqNLQWOcHXaJJoKbi3Qh20EMQbxQC72HrUe16NGXjG_fLdQZ8C6hxttIa6bYdrWuMK0ajLVqg96tmcX6BVs3yYjdj1XzdRbBgtmESGOSHsdpOs3ynSl2H6avmCgV636xSIaWVHVAXtgjRv45e1mC8enOIp9H3z8ubyy_x9ber1eXiOi5TzFjMCK0xV7isMlwxQUmuBFXACp6AEIypqhCAVUmhEElakKTgDHiuspwQjhNFT6Ns33e0HWzvwRjZ9bqFfisJlpMhMhgiKZWpDIbIYIicDAngpz3YjUWrqjIs3cMf2IGWTytWr2XjNjJJBGZ54N8d-N7djcoPstW-VMaAVW70knPKkozhZ4Uk4xQLwoPw7O-NHlc53ESovz3UwQdP6h5sqf2jjKZZlmRZkLG9rOyd972q__tDPv7DlbubctPztXmWRnt6rZv1ve6VDCf3REt_Axv3-po
CODEN JCMIDW
CitedBy_id crossref_primary_10_1128_JCM_01900_07
crossref_primary_10_3390_tropicalmed1010007
crossref_primary_10_1016_j_exppara_2005_12_014
crossref_primary_10_1128_JCM_37_11_3487_3490_1999
crossref_primary_10_1128_JCM_42_10_4593_4598_2004
crossref_primary_10_1128_JCM_03371_15
crossref_primary_10_1128_JCM_38_3_1144_1150_2000
ContentType Journal Article
Copyright 1995 INIST-CNRS
Copyright_xml – notice: 1995 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
M7N
7X8
5PM
ADTOC
UNPAY
DOI 10.1128/jcm.33.4.878-884.1995
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-660X
EndPage 884
ExternalDocumentID 10.1128/jcm.33.4.878-884.1995
PMC228059
7790453
3466266
10_1128_jcm_33_4_878_884_1995
jcm_33_4_878
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
0R~
18M
29K
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
AAGFI
AAYXX
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AGCDD
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GROUPED_DOAJ
GX1
H13
HF~
HYE
HZ~
H~9
KQ8
L7B
O9-
OHT
OK1
P2P
P6G
RHI
RNS
RPM
RSF
TR2
VH1
W8F
WHG
WOQ
X7M
ZCA
ZGI
ZXP
~KM
AGVNZ
IQODW
AAYOK
CGR
CUY
CVF
ECM
EIF
NPM
PKN
RHF
UCJ
YIF
7U9
H94
M7N
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c4055-513f07e0cd60d58319e83ea5b72a8855edb8a0ec3ab824b12b75a79e6911702e3
IEDL.DBID UNPAY
ISSN 0095-1137
1098-660X
1070-633X
IngestDate Wed Aug 20 00:20:20 EDT 2025
Thu Aug 21 18:18:09 EDT 2025
Thu Sep 04 20:23:01 EDT 2025
Fri Sep 05 09:44:24 EDT 2025
Wed Feb 19 01:18:15 EST 2025
Mon Jul 21 09:16:17 EDT 2025
Wed Oct 01 01:18:17 EDT 2025
Thu Apr 24 23:12:00 EDT 2025
Wed May 18 15:26:03 EDT 2016
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Performance evaluation
Human
Immunopathology
Protozoa
Protozoal disease
IgA
IgE
IgG
Isotype
Parasitosis
Method
Immune deficiency
IgM
Infection
Toxoplasma gondii
Toxoplasmosis
Diagnosis
Detection
Sporozoa
Comparative study
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4055-513f07e0cd60d58319e83ea5b72a8855edb8a0ec3ab824b12b75a79e6911702e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://proxy.k.utb.cz/login?url=https://jcm.asm.org/content/jcm/33/4/878.full.pdf
PMID 7790453
PQID 16730817
PQPubID 23462
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_228059
pascalfrancis_primary_3466266
proquest_miscellaneous_16730817
crossref_citationtrail_10_1128_jcm_33_4_878_884_1995
pubmed_primary_7790453
proquest_miscellaneous_77352650
crossref_primary_10_1128_jcm_33_4_878_884_1995
highwire_asm_jcm_33_4_878
unpaywall_primary_10_1128_jcm_33_4_878_884_1995
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 19950401
PublicationDateYYYYMMDD 1995-04-01
PublicationDate_xml – month: 4
  year: 1995
  text: 19950401
  day: 1
PublicationDecade 1990
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Clinical Microbiology
PublicationTitleAlternate J Clin Microbiol
PublicationYear 1995
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References 1517461 - J Clin Pathol. 1992 Jul;45(7):605-8
2342084 - J Med Microbiol. 1990 May;32(1):25-31
1621505 - Acta Neuropathol. 1992;83(5):475-81
3994469 - Arch Intern Med. 1985 May;145(5):925-6
1465928 - Transplant Proc. 1992 Dec;24(6):2754-5
2229363 - J Clin Microbiol. 1990 Oct;28(10):2354-6
2192008 - J Infect Dis. 1990 Jul;162(1):270-3
3882843 - J Immunol Methods. 1985 Feb 28;77(1):15-23
1356529 - Clin Investig. 1992 Jun;70(6):508-12
2778066 - J Clin Microbiol. 1989 Sep;27(9):2031-8
1952867 - Antimicrob Agents Chemother. 1991 Sep;35(9):1914-6
6342373 - Am J Kidney Dis. 1983 May;2(6):615-7
1359410 - N Engl J Med. 1992 Dec 3;327(23):1643-8
8349765 - J Clin Microbiol. 1993 Jul;31(7):1866-9
8263181 - J Clin Microbiol. 1993 Nov;31(11):2952-9
2356447 - Scand J Infect Dis. 1990;22(2):243-4
2903324 - Lancet. 1988 Nov 12;2(8620):1104-7
2697706 - Int Ophthalmol. 1989 Dec;13(6):399-402
3280690 - J Infect. 1988 Mar;16(2):121-8
1970106 - Lancet. 1990 Apr 28;335(8696):988-90
8511127 - Presse Med. 1993 Apr 24;22(15):734
8511144 - Presse Med. 1993 Feb 20;22(6):258-62
1992327 - N Engl J Med. 1991 Feb 28;324(9):634
8018144 - Am J Med. 1993 Dec;95(6):573-83
3619307 - Ann Pediatr (Paris). 1987 May;34(5):375-9
3791840 - Diagn Immunol. 1986;4(5):223-7
3569247 - Eur J Clin Microbiol. 1987 Feb;6(1):1-2
3337515 - Ann Intern Med. 1988 Jan;108(1):49-51
2155947 - J Clin Pathol. 1990 Jan;43(1):63-7
8100291 - Lancet. 1993 Jul 3;342(8862):22-3
2279993 - J Clin Microbiol. 1990 Dec;28(12):2632-6
7901015 - Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):591-5
3121758 - J Infect Dis. 1988 Jan;157(1):1-6
2712547 - Antimicrob Agents Chemother. 1989 Jan;33(1):30-4
3578650 - Am J Trop Med Hyg. 1987 May;36(3):517-22
2951670 - Presse Med. 1987 Mar 21;16(10):471-4
2768467 - J Clin Microbiol. 1989 Aug;27(8):1787-92
2193644 - Zentralbl Bakteriol. 1990 Apr;272(4):514-25
2203811 - J Clin Microbiol. 1990 Aug;28(8):1739-43
References_xml – reference: 2697706 - Int Ophthalmol. 1989 Dec;13(6):399-402
– reference: 2193644 - Zentralbl Bakteriol. 1990 Apr;272(4):514-25
– reference: 8100291 - Lancet. 1993 Jul 3;342(8862):22-3
– reference: 2712547 - Antimicrob Agents Chemother. 1989 Jan;33(1):30-4
– reference: 2192008 - J Infect Dis. 1990 Jul;162(1):270-3
– reference: 2279993 - J Clin Microbiol. 1990 Dec;28(12):2632-6
– reference: 1952867 - Antimicrob Agents Chemother. 1991 Sep;35(9):1914-6
– reference: 3619307 - Ann Pediatr (Paris). 1987 May;34(5):375-9
– reference: 8263181 - J Clin Microbiol. 1993 Nov;31(11):2952-9
– reference: 2951670 - Presse Med. 1987 Mar 21;16(10):471-4
– reference: 2155947 - J Clin Pathol. 1990 Jan;43(1):63-7
– reference: 1992327 - N Engl J Med. 1991 Feb 28;324(9):634
– reference: 7901015 - Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):591-5
– reference: 3882843 - J Immunol Methods. 1985 Feb 28;77(1):15-23
– reference: 2342084 - J Med Microbiol. 1990 May;32(1):25-31
– reference: 2356447 - Scand J Infect Dis. 1990;22(2):243-4
– reference: 3791840 - Diagn Immunol. 1986;4(5):223-7
– reference: 3578650 - Am J Trop Med Hyg. 1987 May;36(3):517-22
– reference: 1465928 - Transplant Proc. 1992 Dec;24(6):2754-5
– reference: 2768467 - J Clin Microbiol. 1989 Aug;27(8):1787-92
– reference: 3994469 - Arch Intern Med. 1985 May;145(5):925-6
– reference: 8511144 - Presse Med. 1993 Feb 20;22(6):258-62
– reference: 3121758 - J Infect Dis. 1988 Jan;157(1):1-6
– reference: 2203811 - J Clin Microbiol. 1990 Aug;28(8):1739-43
– reference: 2229363 - J Clin Microbiol. 1990 Oct;28(10):2354-6
– reference: 2903324 - Lancet. 1988 Nov 12;2(8620):1104-7
– reference: 6342373 - Am J Kidney Dis. 1983 May;2(6):615-7
– reference: 1356529 - Clin Investig. 1992 Jun;70(6):508-12
– reference: 3569247 - Eur J Clin Microbiol. 1987 Feb;6(1):1-2
– reference: 1517461 - J Clin Pathol. 1992 Jul;45(7):605-8
– reference: 8018144 - Am J Med. 1993 Dec;95(6):573-83
– reference: 3280690 - J Infect. 1988 Mar;16(2):121-8
– reference: 1970106 - Lancet. 1990 Apr 28;335(8696):988-90
– reference: 3337515 - Ann Intern Med. 1988 Jan;108(1):49-51
– reference: 8511127 - Presse Med. 1993 Apr 24;22(15):734
– reference: 8349765 - J Clin Microbiol. 1993 Jul;31(7):1866-9
– reference: 2778066 - J Clin Microbiol. 1989 Sep;27(9):2031-8
– reference: 1621505 - Acta Neuropathol. 1992;83(5):475-81
– reference: 1359410 - N Engl J Med. 1992 Dec 3;327(23):1643-8
SSID ssj0014455
Score 1.6387063
Snippet Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by...
SourceID unpaywall
pubmedcentral
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 878
SubjectTerms Adolescent
Adult
AIDS-Related Opportunistic Infections - complications
AIDS-Related Opportunistic Infections - diagnosis
AIDS-Related Opportunistic Infections - immunology
Animals
Antibodies, Protozoan - analysis
Antibody Specificity
Biological and medical sciences
Evaluation Studies as Topic
Human protozoal diseases
Humans
Immunoassay - methods
Immunoassay - statistics & numerical data
Immunocompromised Host
Immunoglobulin A - analysis
Immunoglobulin E - analysis
Immunoglobulin G - analysis
Immunoglobulin M - analysis
Infectious diseases
Medical sciences
Middle Aged
Parasitic diseases
Protozoal diseases
Risk Factors
Sensitivity and Specificity
Toxoplasma - immunology
Toxoplasma gondii
Toxoplasmosis
Toxoplasmosis - complications
Toxoplasmosis - diagnosis
Toxoplasmosis - immunology
Transplantation Immunology
Title Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients
URI http://jcm.asm.org/content/33/4/878.abstract
https://www.ncbi.nlm.nih.gov/pubmed/7790453
https://www.proquest.com/docview/16730817
https://www.proquest.com/docview/77352650
https://pubmed.ncbi.nlm.nih.gov/PMC228059
https://jcm.asm.org/content/jcm/33/4/878.full.pdf
UnpaywallVersion publishedVersion
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1098-660X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014455
  issn: 1098-660X
  databaseCode: KQ8
  dateStart: 19750101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1098-660X
  dateEnd: 20250404
  omitProxy: true
  ssIdentifier: ssj0014455
  issn: 1098-660X
  databaseCode: DIK
  dateStart: 19750101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1098-660X
  dateEnd: 20250404
  omitProxy: true
  ssIdentifier: ssj0014455
  issn: 1098-660X
  databaseCode: GX1
  dateStart: 19750101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1098-660X
  dateEnd: 20241004
  omitProxy: true
  ssIdentifier: ssj0014455
  issn: 1098-660X
  databaseCode: RPM
  dateStart: 19750101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELe2Tny88DE2EWDDDzyAtKRJbMfOY4U6VlAnQJtUniIncUqhTQptBeWf41_jzkkjyodgT43iO1txfj2f47vfEfJEGWZ8qYULy6lwuea5G_th5hrBMSE4k6GtRTA8j84u-cuRGO2QYJML8yGbeXoxs2f4GKwNlhfvdRnr8q6SysOv0t48L3bJXoRnSh2yd3n-uveuZpsUblDzZMKuBrZFjI3sdaxcEB41GTxgku04jHncgz5dpThm7YnttWnDF4zhknoBM1bUpS7-5Iv-HlJ5Y1XO9fqLnk5_Wq9Ob5O3myetw1Q-eqtl6mXffiGBvNJU3CG3Gu-V9mq43SU7ptwn1-p6lut9cn3YnNTfI9_7LY04rQqKEexUlznN69A-0KcoYLDx00qXNtcNLC8FZ16vFxR8aYp33YvqazUHF3-m6bgq88mETjClpUImE4yipz36dDDuPTuhg3H_xI4xGA_tr0bCFfutnloWXRwLM0sxOgqEXlDQrjvLDRJpwKPThmd2cUAuT_sXz8_cpliEm4HPKVwRsMKXxs_yyM-FAstiFDNapDLUSglh8lRp32RMpyrkaRCmUmgZmyjG2juhYYekU1aluU9obHJYwrnPs1TygktlCq7CIBOpSXmgC4fwDUySrGFSx4Ie08TuqEKVwGtKGEt4Aq8pAXQliC6HeK3avKYS-ZeCs8FgAtO8JeSQoy1Qtj0yHsEeNXLI4w1IEzAYeAqkS1OtFkkQgVFXgfy7hJS2aILvkMMa1G3nSE7JBXNItIX2th25yrdbysl7y1mOrEsidki3_Vv83xw8uLLGQ3Kzph3A6KpHpLP8vDJH4Dgu02Oy--qNOm4Mxg_CtWtZ
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELaWrnhceCy7IsCCDxxA2qRJbMfOsUJddpG6QmgrlVPkJE4ptEmhraD8Of4aM85DlIdgT43iGVtxvo7H8cw3hDxThhlfauHCcipcrnnuxn6YuUZwTAjOZGhrEYwuorMxfz0Rkz0StLkwH7KFp1cLe4aPwdpgefFen7E-7yupPPwq7S3z4hrZj_BMqUf2xxdvBu9qtknhBjVPJuxqYFvE2MRex8oF4UmTwQMm2Y7DmMc96NNVimPWnthdm1q-YAyX1CuYsaIudfEnX_T3kMqbm3Kpt1_0fP7TenV6h7xtn7QOU_nobdapl337hQTySlNxl9xuvFc6qOF2j-yZ8oBcr-tZbg_IjVFzUn-ffB92NOK0KihGsFNd5jSvQ_tAn6KAwcZPG13aXDewvBSceb1dUfClKd51L6uv1RJc_IWm06rMZzM6w5SWCplMMIqeDujz8-ngxQk9nw5P7Bjn05H91Ui4Yr_VU8uii2NhZilGR4HQKwradWe5QSINeHTa8MyuDsn4dHj58sxtikW4GficwhUBK3xp_CyP_FwosCxGMaNFKkOtlBAmT5X2TcZ0qkKeBmEqhZaxiWKsvRMadkR6ZVWaB4TGJoclnPs8SyUvuFSm4CoMMpGalAe6cAhvYZJkDZM6FvSYJ3ZHFaoEXlPCWMITeE0JoCtBdDnE69SWNZXIvxScFoMJTPOOkEOOd0DZ9ch4BHvUyCFPW5AmYDDwFEiXptqskiACo64C-XcJKW3RBN8hRzWou86RnJIL5pBoB-1dO3KV77aUs_eWsxxZl0TskH73t_i_OXh4ZY1H5FZNO4DRVY9Jb_15Y47BcVynTxpT8QNEPGpk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+risk+and+diagnostic+value+of+quantitative+assays+for+anti-Toxoplasma+gondii+immunoglobulin+A+%28IgA%29%2C+IgE%2C+and+IgM+and+analytical+study+of+specific+IgG+in+immunodeficient+patients&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Pinon%2C+J+M&rft.au=Foudrinier%2C+F&rft.au=Mougeot%2C+G&rft.au=Marx%2C+C&rft.date=1995-04-01&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=33&rft.issue=4&rft.spage=878&rft.epage=884&rft_id=info:doi/10.1128%2Fjcm.33.4.878-884.1995&rft_id=info%3Apmid%2F7790453&rft.externalDocID=PMC228059
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon